Loi n° 5-2026 du 25 juin 2026

Complete seven-article law and all signatures, printed pages 801–802 of the 16 July 2026 Gazette. Establishes INBVS in Pointe-Noire under health, finance, budget and public-accounting supervision. Article 3 assigns quality control of reagents, biological products, medical fluids and other covered consumables, and expert assessment for initial and renewed marketing-authorisation applications for medicines and reagents. It also assigns laboratory-network surveillance and health-product vigilance functions. Conformity/health-quality controls are borne by manufacturers, importers or others requesting release for consumption, with procedures requiring a separate decree; Article 6 separately requires approved institutional statutes. This law does not itself state a general device-variation procedure, review time or numerical tariff, and does not expressly repeal or replace the existing LNSP. Both official issue-29 file variants have pixel-identical original pages for this law; an alternate catalogue’s April date is erroneous, while both covers state 16 July. All original text, column order, signatures and both original-page images are retained. Implementing measures and later changes remain under review.

Loi n° 5-2026 du 25 juin 2026 is the official identifier INBVS / MSP uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.